A multiple ascending dose, randomized, double-blind, placebo-controlled, phase I clinical trial in healthy male Japanese volunteers to determine the safety, tolerability, and pharmacokinetic parameters of naldemedine.

Trial Profile

A multiple ascending dose, randomized, double-blind, placebo-controlled, phase I clinical trial in healthy male Japanese volunteers to determine the safety, tolerability, and pharmacokinetic parameters of naldemedine.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2017

At a glance

  • Drugs Naldemedine (Primary)
  • Indications Constipation
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 24 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top